Published in Blood Weekly, October 23rd, 1995
The research was presented at the American Medical Association's (AMA) 14th annual Science Reporters Conference.
Werner Hacke, M.D., from the University of Heidelberg, Germany, Markku Kaste, M.D., from the University of Helsinki, Finland, and colleagues found that recombinant tissue plasminogen activator (rt-PA), when administered within six hours of the onset of stroke symptoms, can improve some functional measures in stroke patients who have suffered...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.